Clinical Trial Update: Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating eltoprazine for cognitive impairment associated with schizophrenia in adults has completed. The study was sponsored by Amarant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Eltoprazine (eltoprazine)

Snippet

Sponsor: Amarantus BioScience Holdings, Inc. | Conditions: Cognitive Impairment, Schizophrenia | Phase 2 | Status: COMPLETED